APA (7th ed.) Citation

J, L. C., J, T., P, S., MS, C., SC, F., SC, G., & ND, S. (2025). Plain language review: The safety of relugolix combination therapy for advanced prostate cancer. Future oncology (London, England), 21(1), 51. https://doi.org/10.1080/14796694.2024.2409543

Chicago Style (17th ed.) Citation

J, La Cerda, Thorley J, Sieber P, Cookson MS, Flanders SC, Gatoulis SC, and Shore ND. "Plain Language Review: The Safety of Relugolix Combination Therapy for Advanced Prostate Cancer." Future Oncology (London, England) 21, no. 1 (2025): 51. https://doi.org/10.1080/14796694.2024.2409543.

MLA (9th ed.) Citation

J, La Cerda, et al. "Plain Language Review: The Safety of Relugolix Combination Therapy for Advanced Prostate Cancer." Future Oncology (London, England), vol. 21, no. 1, 2025, p. 51, https://doi.org/10.1080/14796694.2024.2409543.